| Copper | Approved Investigational | SCEL | 8796 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SCEL mRNA | 13q22.3 | |
| Copper | Approved Investigational | SCFD2 | 152579 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SCFD2 mRNA | 4q12 | |
| Copper | Approved Investigational | SCG5 | 6447 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SCG5 mRNA | 15q13.3 | |
| Copper | Approved Investigational | SCIN | 85477 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SCIN mRNA | 7p21.3 | |
| Copper | Approved Investigational | SCN8A | 6334 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SCN8A mRNA | 12q13.13 | |
| Copper | Approved Investigational | SCNM1 | 79005 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of SCNM1 mRNA | 1q21.3 | |
| Copper | Approved Investigational | SCRN2 | 90507 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SCRN2 mRNA | 17q21 | |
| Copper | Approved Investigational | SCYL2 | 55681 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SCYL2 mRNA | 12q23.1 | |
| Copper | Approved Investigational | SDC1 | 6382 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SDC1 mRNA | 2p24.1 | |
| Copper | Approved Investigational | SDCCAG8 | 10806 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SDCCAG8 mRNA | 1q43-q44 | |
| Copper | Approved Investigational | SDHA | 6389 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SDHA mRNA | 5p15.33 | |
| Copper | Approved Investigational | SEC11C | 90701 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SEC11C mRNA | 18q21.32 | |
| Copper | Approved Investigational | SEC24D | 9871 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SEC24D mRNA | 4q26 | |
| Copper | Approved Investigational | SEC61B | 10952 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA | 9q22.33 | |
| Copper | Approved Investigational | SEC62 | 7095 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SEC62 mRNA | 3q26.2 | |
| Copper | Approved Investigational | SEL1L | 6400 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SEL1L mRNA | 14q31 | |
| Copper | Approved Investigational | SEL1L3 | 23231 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of SEL1L3 mRNA | 4p15.2 | |
| Copper | Approved Investigational | SEL1L3 | 23231 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SEL1L3 mRNA | 4p15.2 | |
| Copper | Approved Investigational | SELENOK | 58515 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SELENOK mRNA | 3p21.1 | |
| Copper | Approved Investigational | SEM1 | 7979 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of SEM1 mRNA | 7q21.3 | |
| Copper | Approved Investigational | SEMA4D | 10507 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of SEMA4D mRNA | 9q22.2 | |
| Copper | Approved Investigational | SEPHS1 | 22929 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SEPHS1 mRNA | 10p13 | |
| Copper | Approved Investigational | SEPT11 | 55752 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SEPT11 mRNA | 4q21.1 | |
| Copper | Approved Investigational | SEPT6 | 23157 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SEPT6 mRNA | Xq24 | |
| Copper | Approved Investigational | SEPT8 | 23176 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of SEPT8 mRNA | 5q31.1 | |